Tonix Pharma (TNXP)
NASDAQ:TNXP
Holding TNXP?
Track your performance easily

Tonix Pharma (TNXP) Financial Statements

2,622 Followers

Tonix Pharma Financial Overview

Tonix Pharma's market cap is currently ―. The company's EPS TTM is $-22.153; its P/E ratio is >-0.01; Tonix Pharma is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-2.93. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 2.21M$ 2.48M$ 3.99M--
Gross Profit$ -1.16M$ 822.00K$ 1.61M--
EBIT$ -78.78M$ -14.94M$ -28.15M$ -28.36M$ 34.80M
EBITDA$ -77.44M$ -13.43M$ -26.93M$ -27.43M$ 35.69M
Net Income Common Stockholders$ -78.78M$ -14.94M$ -27.98M$ -28.36M$ 34.80M
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 4.16M$ 7.05M$ 6.91M$ 25.62M$ 71.97M
Total Assets$ 70.31M$ 135.34M$ 139.28M$ 159.74M$ 179.09M
Total Debt$ 9.26M$ 9.82M$ 1.15M$ 1.27M$ 1.03M
Net Debt$ 5.10M$ 2.77M$ -5.76M$ -24.35M$ -70.95M
Total Liabilities$ 28.20M$ 27.20M$ 18.45M$ 19.27M$ 13.66M
Stockholders Equity$ 42.10M$ 108.14M$ 120.83M$ 140.46M$ 165.43M
Cash Flow-
Free Cash Flow$ -9.92M$ -17.68M$ -24.21M$ -25.22M$ -36.70M
Operating Cash Flow$ -9.92M$ -17.57M$ -23.39M$ -23.37M$ -32.91M
Investing Cash Flow-$ -108.00K$ -821.00K$ -24.02M$ -3.80M
Financing Cash Flow$ 7.03M$ -212.00K$ 6.27M$ 1.03M$ -11.50M
Currency in USD

Tonix Pharma Earnings and Revenue History

Tonix Pharma Debt to Assets

Tonix Pharma Cash Flow

Tonix Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis